Evidence map›Paper›PMID 37357611›Full record

ArticleJournal of cell science2023

Src- and Abl-family kinases activate spleen tyrosine kinase to maximize phagocytosis and Leishmania infection.

Imran Ullah, Umaru Barrie, Rebecca M Kernen, Emily T Mamula, Francis Tho Huu Khuong, Laela M Booshehri, Emma L Rhodes, James M Bradford, Arani Datta, Dawn M Wetzel

Open access · hybridAbstract read
In one paragraph

Article in Journal of cell science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. DNA Methylation in macrophages infected withEmerging microbes & infections · 2025
    Article
  2. Article
  3. Article
  4. Using machine learning to dissect host kinases required forbioRxiv : the preprint server for biology · 2024
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Imran UllahDepartment of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.ORCID 0000-0003-1432-1705
Umaru BarrieDepartment of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.ORCID 0000-0002-0365-7070
Rebecca M KernenDepartment of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.
Emily T MamulaDepartment of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.
Francis Tho Huu KhuongDepartment of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.ORCID 0000-0002-6566-1657
Laela M BooshehriDepartment of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.ORCID 0000-0003-0175-9468
Emma L RhodesDepartment of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.ORCID 0000-0002-9994-3898
James M BradfordDepartment of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.ORCID 0000-0003-0730-152X
Arani DattaDepartment of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.ORCID 0000-0002-2459-5964
Dawn M WetzelDepartment of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.ORCID 0000-0002-3990-7043
The University of Texas Southwestern Medical Center · US

Funding

TRAINING THE MD PHD IN THE HEALTH SCIENCE CENTERT32GM008014 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI ZINN, ANDREW R. · 1985 to 2024
$21.1M
Targeting a New Therapy for TrypanosomatidsR01AI146349 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI WETZEL, DAWN MARIE · 2019 to 2023
$3.0M
Targeting Entry Pathways in LeishmaniasisK08AI103036 · NIAID · YALE UNIVERSITY · PI WETZEL, DAWN MARIE · 2013 to 2015
$397k
NIAID NIH HHS K08 AI103036NIAID NIH HHS R01 AI146349NIGMS NIH HHS T32 GM008014NIH HHS K08 AI103036
6 · The paper itself

Abstract

Leishmania spp. are obligate intracellular parasites that must be internalized by phagocytic cells to evade immune responses and cause disease. The uptake of both Leishmania promastigotes (insect-stage parasites) and amastigotes (proliferative-stage parasites in humans and mice) by phagocytes is thought to be mainly host cell driven, not parasite driven. Our previous work indicates that host Src- and Abl-family kinases facilitate Leishmania entry into macrophages and pathogenesis in murine cutaneous leishmaniasis. Here, we demonstrate that host spleen tyrosine kinase (SYK) is required for efficient uptake of Leishmania promastigotes and amastigotes. A Src-family kinase-Abl-family kinase-SYK signaling cascade induces Leishmania amastigote internalization. Finally, lesion size and parasite burden during Leishmania infection is significantly decreased in mice lacking SYK in monocytes or by treatment with the SYK inhibitor entospletinib. In summary, SYK is required for maximal Leishmania uptake by macrophages and disease in mice. Our results suggest potential for treating leishmaniasis using host cell-directed agents.

Indexed as

LeishmaniaLeishmaniasisParasitesAnimalsHumansMacrophagesMicePhagocytosisSyk KinaseSyk KinaseKinaseLeishmaniaMacrophageParasitePathogen

Identifiers

PMID37357611
PMCPMC10399977
OpenAlexW4382011793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.